OpenRegistry
Companies House/Reading/Company profile

NANOLIPO CANCER SOLUTIONS LIMITED

Active
16795773·incorporated 2025-10-20

NANOLIPO CANCER SOLUTIONS LIMITED is an active UK private limited company, incorporated on 20 October 2025 at Companies House (number 16795773; OpenRegistry canonical ID GB-16795773-nanolipo-cancer-solutions-limited). Sophymarine's OpenRegistry classifies it under SIC 21200 (Manufacture of pharmaceutical preparations), one of 553 active UK entities in that code and one of 25,207 active companies registered in Reading (postcode RG1). Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.

Status
Active
Type
Private Limited Company
Incorporated
2025-10-20
Registered Address
45 UPPER REDLANDS ROAD, READING, RG1 5JE, ENGLAND
SIC
21200 — Manufacture of pharmaceutical preparations
Country of origin
United Kingdom

Accounts

Next accounts due 2027-07-20. Financial year-end: 31/10. Filing class: NO ACCOUNTS FILED.

Confirmation statement

Next confirmation statement due 2026-11-02.

Persons with significant control

NANOLIPO CANCER SOLUTIONS LIMITED has 2 persons with significant control on file:

  • Arghavan Salami born 1995 resident in England, Iranian national. Notified 2025-10-20.
    • Owns 50–75% of shares
    • Holds 50–75% of voting rights
    • Has the right to appoint and remove directors
  • Mr Costin Petre Arnautu born 1993 resident in England, Romanian national. Notified 2025-10-20.
    • Owns 25–50% of shares
    • Owns 25–50% of shares
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights
    • Holds 25–50% of voting rights
    • Holds 25–50% of voting rights
    • Has the right to appoint and remove directors
    • Right To Appoint And Remove Directors As Firm
    • Significant Influence Or Control As Firm

Similar UK companies

Other companies registered under SIC 21200 (Manufacture of pharmaceutical preparations):

Other companies registered in Reading: